Chest, Vol 100, 7-13, Copyright © 1991 by American College of Chest Physicians

ARTICLES

Nosocomial pneumonia and the role of gastric pH. A meta-analysis

DJ Cook, LA Laine, GH Guyatt and TA Raffin
Department of Medicine, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada.

PURPOSE: To examine the differential effect of drugs used for stress ulcer prophylaxis on nosocomial pneumonia in critically ill patients. DATA IDENTIFICATION: Computerized bibliographic search of published and unpublished research. STUDY SELECTION: Independent review of 48 randomized controlled trials of prophylaxis identified eight relevant studies. DATA ABSTRACTION: The population, intervention, and outcomes were evaluated by duplicate independent review. RESULTS: The incidence of pneumonia was lower in critically ill patients receiving antacids and/or histamine-2-receptor antagonists as compared with patients receiving no stress ulcer prophylaxis (common odds ratio 0.42, 95 percent CI 0.17 to 1.11). When stress ulcer prophylactic therapy was titrated to achieve a gastric pH of 3.5 or greater, there was a trend favoring a decreased incidence of pneumonia (0.66, 95 percent CI 0.24 to 1.78). In trials comparing sucralfate with pH-altering drugs, the common odds ratio of 0.55 (0.28 to 1.06) suggests a 45 percent risk reduction with the use of sucralfate. CONCLUSION: Stress ulcer prophylaxis with drugs which raise gastric pH does not increase the incidence of pneumonia in comparison to placebo or control therapy. The use of sucralfate is associated with a lower incidence of nosocomial pneumonia in comparison to agents which raise gastric pH. However, methodologic deficiencies, small sample sizes, and the failure to examine the effects of antacids and histamine-2-receptor antagonists separately make a large prospective randomized trial necessary to confirm or refute these findings.

This article has been cited by other articles:

				G. S. Martin Temporal Changes in Clinical Outcomes With ARDS Chest, August 1, 2005; 128(2): 479 - 481. [Full Text] [PDF]

				C. J Coursol and S. E Sanzari Impact of Stress Ulcer Prophylaxis Algorithm Study Ann. Pharmacother., May 1, 2005; 39(5): 810 - 816. [Abstract] [Full Text] [PDF]

				H. R. Collard, S. Saint, and M. A. Matthay Prevention of Ventilator-Associated Pneumonia: An Evidence-Based Systematic Review Ann Intern Med, March 18, 2003; 138(6): 494 - 501. [Abstract] [Full Text] [PDF]

				U. Janssens, H. Groesdonk, J. Graf, P. W. Radke, W. Lepper, and P. Hanrath Comparison of oesophageal and gastric air tonometry in patients with circulatory failure Br. J. Anaesth., August 1, 2002; 89(2): 237 - 241. [Abstract] [Full Text] [PDF]

				G. M. Mutlu, E. A. Mutlu, and P. Factor GI Complications in Patients Receiving Mechanical Ventilation Chest, April 1, 2001; 119(4): 1222 - 1241. [Abstract] [Full Text] [PDF]

				R. S. Morehead and S. J. Pinto Ventilator-Associated Pneumonia Arch Intern Med, July 10, 2000; 160(13): 1926 - 1936. [Abstract] [Full Text] [PDF]

				J.-L. Vincent Prevention of nosocomial bacterial pneumonia Thorax, June 1, 1999; 54(6): 544 - 549. [Full Text]

				A. B. Nathens and J. C. Marshall Selective Decontamination of the Digestive Tract in Surgical Patients: A Systematic Review of the Evidence Arch Surg, February 1, 1999; 134(2): 170 - 176. [Abstract] [Full Text] [PDF]

				P. E. Marik Analytic Reviews : Stress Ulcer Prophylaxis: A Practical Approach J Intensive Care Med, January 1, 1999; 14(1): 1 - 8. [PDF]

				K. S. Ephgrave, R. Kleiman-Wexler, M. Pfaller, B. M. Booth, D. Reed, L. Werkmeister, and S. Young Effects of Sucralfate vs Antacids on Gastric Pathogens: Results of a Double-blind Clinical Trial Arch Surg, March 1, 1998; 133(3): 251 - 257. [Abstract] [Full Text] [PDF]

				T M Cook Criticism of prophylaxis of gastrointestinal bleeding with H2 receptor antagonists is wrong BMJ, August 9, 1997; 315(7104): 371 - 372. [Full Text]